https://www.nejm.org/doi/full/10.1056/NEJMoa2201737
Original Article from The New England Journal of Medicine — Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis
Create an account or login to join the discussion